All Pharma News
BioCryst Reports Q2 2024 Results And Business Update

BioCryst Reports Q2 2024 Results And Business Update
GLOBENEWSWIRE
05 Aug 2024
Share Share
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
02 Aug 2024
Share Share
BioCryst to Report Second Quarter 2024 Financial Results on August 5

BioCryst to Report Second Quarter 2024 Financial Results on August 5
GLOBENEWSWIRE
22 Jul 2024
Share Share
ORLADEYO® (berotralstat) Approved in Peru

ORLADEYO® (berotralstat) Approved in Peru
GLOBENEWSWIRE
09 Jul 2024
Share Share
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
02 Jul 2024
Share Share
KalVista files first oral on-demand HAE drug with FDA

KalVista files first oral on-demand HAE drug with FDA
Phil Taylor PHARMAPHORUM
18 Jun 2024
Share Share
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
04 Jun 2024
Share Share
BioCryst To Present Data At EAACI 2024 Meeting

BioCryst To Present Data At EAACI 2024 Meeting
GLOBENEWSWIRE
14 May 2024
Share Share
BioCryst ORLADEYO Real-World Evidence At HAE Conference

BioCryst ORLADEYO Real-World Evidence At HAE Conference
GLOBENEWSWIRE
09 May 2024
Share Share
BioCryst to Present at Upcoming Investor Conferences

BioCryst to Present at Upcoming Investor Conferences
GLOBENEWSWIRE
07 May 2024
Share Share